127 related articles for article (PubMed ID: 8830337)
21. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.
Gudgeon AM; Heath DI; Hurley P; Jehanli A; Patel G; Wilson C; Shenkin A; Austen BM; Imrie CW; Hermon-Taylor J
Lancet; 1990 Jan; 335(8680):4-8. PubMed ID: 1967341
[TBL] [Abstract][Full Text] [Related]
22. Sequential changes in pancreatic markers in acute pancreatitis.
Lempinen M; Stenman UH; Puolakkainen P; Hietaranta A; Haapiainen R; Kemppainen E
Scand J Gastroenterol; 2003 Jun; 38(6):666-75. PubMed ID: 12825877
[TBL] [Abstract][Full Text] [Related]
23. Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases.
Mansfield CS; Jones BR
Aust Vet J; 2000 Jun; 78(6):416-22. PubMed ID: 10920782
[TBL] [Abstract][Full Text] [Related]
24. Assay of trypsinogen activation in the cat experimental model of acute pancreatitis.
Karanjia ND; Widdison AL; Jehanli A; Hermon-Taylor J; Reber HA
Pancreas; 1993 Mar; 8(2):189-95. PubMed ID: 8460094
[TBL] [Abstract][Full Text] [Related]
25. Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.
Allen HS; Steiner J; Broussard J; Mansfield C; Williams DA; Jones B
Can J Vet Res; 2006 Oct; 70(4):313-6. PubMed ID: 17042387
[TBL] [Abstract][Full Text] [Related]
26. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive rapid urinary trypsinogen-2 dipstick test for early exclusion of post-endoscopic retrograde cholangiopancreatography pancreatitis within hours after endoscopic retrograde cholangiopancreatography: Clinical diagnosis and considerations.
Hama K; Sofuni A; Nakatsubo R; Tsuchiya T; Tanaka R; Tonozuka R; Mukai S; Yamamoto K; Katanuma A; Itoi T
DEN Open; 2024 Apr; 4(1):e336. PubMed ID: 38389803
[TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of trypsinogen activation peptide (TAP) in taurocholate-induced pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Hayakawa T
Pancreas; 2001 Jan; 22(1):24-7. PubMed ID: 11138966
[TBL] [Abstract][Full Text] [Related]
29. Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis.
Petersson U; Borgström A
JOP; 2006 May; 7(3):274-82. PubMed ID: 16685108
[TBL] [Abstract][Full Text] [Related]
30. Urinary trypsinogen-2 for diagnosing acute pancreatitis: a meta-analysis.
Jin T; Huang W; Jiang K; Xiong JJ; Xue P; Javed MA; Yang XN; Xia Q
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):355-62. PubMed ID: 23924492
[TBL] [Abstract][Full Text] [Related]
31. Ligation-induced acute pancreatitis increases pancreatic circulating trypsinogen activation peptides.
Merriam LT; Wilcockson D; Samuel I; Joehl RJ
J Surg Res; 1996 Feb; 60(2):417-21. PubMed ID: 8598679
[TBL] [Abstract][Full Text] [Related]
32. Repeated Negative Urine Trypsinogen-2 Dipstick Test Rules Out Diagnosis of Post-ERCP Pancreatitis.
Rainio M; Lindström O; Udd M; Puolakkainen P; Stenman UH; Kylänpää L
J Clin Gastroenterol; 2021 Apr; 55(4):361-366. PubMed ID: 32925303
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis.
Kemppainen E; Hietaranta A; Puolakkainen P; Sainio V; Halttunen J; Haapiainen R; Kivilaakso E; Nevalainen T
Pancreas; 1999 Jan; 18(1):21-7. PubMed ID: 9888656
[TBL] [Abstract][Full Text] [Related]
34. Local and systemic zymogen activation in human acute pancreatitis.
Mayer JM; Rau B; Siech M; Beger HG
Digestion; 2000; 62(2-3):164-70. PubMed ID: 11025364
[TBL] [Abstract][Full Text] [Related]
35. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine.
Lempinen M; Kylänpää-Bäck ML; Stenman UH; Puolakkainen P; Haapiainen R; Finne P; Korvuo A; Kemppainen E
Clin Chem; 2001 Dec; 47(12):2103-7. PubMed ID: 11719473
[TBL] [Abstract][Full Text] [Related]
36. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis.
Kemppainen EA; Hedström JI; Puolakkainen PA; Sainio VS; Haapiainen RK; Perhoniemi V; Osman S; Kivilaakso EO; Stenman UH
N Engl J Med; 1997 Jun; 336(25):1788-93. PubMed ID: 9187069
[TBL] [Abstract][Full Text] [Related]
37. [Urinary trypsinogen activation peptide (TAP)].
Naruse S
Nihon Rinsho; 2004 Nov; 62 Suppl 11():131-2. PubMed ID: 15628355
[No Abstract] [Full Text] [Related]
38. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis.
Oezcueruemez-Porsch M; Kunz D; Hardt PD; Fadgyas T; Kress O; Schulz HU; Schnell-Kretschmer H; Temme H; Westphal S; Luley C; Kloer HU
Dig Dis Sci; 1998 Aug; 43(8):1763-9. PubMed ID: 9724166
[TBL] [Abstract][Full Text] [Related]
39. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis.
Heath DI; Cruickshank A; Gudgeon AM; Jehanli A; Shenkin A; Imrie CW
Pancreas; 1995 May; 10(4):347-53. PubMed ID: 7540760
[TBL] [Abstract][Full Text] [Related]
40. Serum and urine trypsinogen activation peptide in assessing post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pezzilli R; Mariani A; Gabbrielli A; Morselli-Labate AM; Barassi A
Pancreas; 2010 Jan; 39(1):108-10. PubMed ID: 20019567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
